Globus Medical Q2 revenue $251M (+68.6% YoY); raises FY2021 guidance to $950M sales, $1.89-2.00 EPS

GLOBUS MEDICAL INC

2021-Q2 EPS reported $0.84 revenue$478,360,000

Q2 worldwide net sales of $251.0M, up 68.6% YoY; GAAP net income $41.5M (16.6% of sales), up 299.4% YoY.
GAAP diluted EPS $0.40, Non-GAAP diluted EPS $0.56, compared to ($0.21) and $0.07 in Q2 2020 respectively.
U.S. Spine business grew ~64% YoY; Enabling Technologies revenue $21M (nearly 4x Q2 2020).
Raised FY2021 guidance: net sales to $950M (from $925M) and non-GAAP diluted EPS to $1.89-$2.00.
Cash and marketable securities $914.2M, no debt; generated $59.2M operating cash flow, $50.8M free cash flow in Q2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.